loading
Applied Therapeutics Inc stock is traded at $0.00, with a volume of 0. It is down -100.00% in the last 24 hours and down -100.00% over the past month. Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
See More
Previous Close:
$0.103
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$14.86M
Revenue:
-
Net Income/Loss:
$-119.76M
P/E Ratio:
0.00
EPS:
-1.35
Net Cash Flow:
$-55.17M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
Value
$0.00
$0.00
1-Week Range:
Value
$0.00
$0.00
52-Week Range:
Value
$0.00
$1.50

Applied Therapeutics Inc Stock (APLT) Company Profile

Name
Name
Applied Therapeutics Inc
Name
Phone
212-220-9226
Name
Address
545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY
Name
Employee
28
Name
Twitter
@Applied_Tx
Name
Next Earnings Date
2025-03-31
Name
Latest SEC Filings
Name
APLT's Discussions on Twitter

Compare APLT vs VRTX, REGN, ARGX, ALNY, ONC

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
APLT icon
APLT
Applied Therapeutics Inc
0.00 14.86M 0 -119.76M -55.17M -1.35
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
427.28 109.41B 12.07B 3.95B 3.19B 15.33
REGN icon
REGN
Regeneron Pharmaceuticals Inc
707.06 76.72B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
781.72 48.20B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
309.20 40.31B 3.71B 313.75M 465.38M 2.2571
ONC icon
ONC
Beone Medicines Ltd Adr
295.27 33.13B 5.36B 287.73M 924.18M 2.5229

Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-12-25 Downgrade Robert W. Baird Outperform → Neutral
Dec-03-25 Downgrade Leerink Partners Outperform → Market Perform
Dec-23-24 Downgrade William Blair Outperform → Mkt Perform
Dec-02-24 Downgrade UBS Buy → Neutral
Nov-29-24 Downgrade RBC Capital Mkts Outperform → Sector Perform
Jul-31-24 Initiated William Blair Outperform
Mar-26-24 Initiated RBC Capital Mkts Outperform
Feb-22-24 Initiated Leerink Partners Outperform
Jan-04-22 Downgrade Barclays Overweight → Equal Weight
Aug-27-21 Downgrade Goldman Neutral → Sell
Jun-25-21 Resumed Goldman Neutral
Oct-08-20 Initiated Truist Buy
Apr-22-20 Initiated Goldman Buy
Feb-27-20 Initiated Barclays Overweight
Jun-10-19 Initiated Citigroup Buy
Jun-10-19 Initiated Cowen Outperform
Jun-10-19 Initiated Robert W. Baird Outperform
View All

Applied Therapeutics Inc Stock (APLT) Latest News

pulisher
Apr 27, 2026

Here's why Applied Therapeutics (APLT) is a great 'buy the bottom' stock now - MSN

Apr 27, 2026
pulisher
Apr 26, 2026

Applied Therapeutics (APLT) Upgraded to Buy: Here's Why - MSN

Apr 26, 2026
pulisher
Apr 18, 2026

Applied Therapeutics, Inc. (APLT) - Minichart

Apr 18, 2026
pulisher
Apr 13, 2026

Aug Swings: Should I set a stop loss on Applied Therapeutics Inc2026 Review & Safe Entry Momentum Tips - baoquankhu1.vn

Apr 13, 2026
pulisher
Apr 13, 2026

Panic Selling: Is Applied Therapeutics Inc backed by strong institutional buyingQuarterly Trade Review & AI Enhanced Trading Alerts - baoquankhu1.vn

Apr 13, 2026
pulisher
Apr 10, 2026

New Highs: Can Applied Therapeutics Inc keep up with sector leaders2026 Major Catalysts & Daily Risk Controlled Trade Plans - baoquankhu1.vn

Apr 10, 2026
pulisher
Apr 10, 2026

Momentum Shift: What is Applied Therapeutics Incs valuation compared to sectorMarket Activity Summary & Low Risk Entry Point Guides - baoquankhu1.vn

Apr 10, 2026
pulisher
Apr 10, 2026

Aug Movers: Is Applied Therapeutics Inc stock good for income investors2026 Macro Impact & Weekly Return Optimization Alerts - baoquankhu1.vn

Apr 10, 2026
pulisher
Apr 06, 2026

Aug Volume: Can Applied Therapeutics Inc continue delivering strong returns2026 PostEarnings & Real-Time Stock Price Movement Reports - baoquankhu1.vn

Apr 06, 2026
pulisher
Apr 06, 2026

Retail Traders Cheer Applied Therapeutics Data On Rare Nerve Disease Drug - MSN

Apr 06, 2026
pulisher
Mar 31, 2026

APLT Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Mar 31, 2026
pulisher
Mar 30, 2026

Earnings Report: Can Applied Therapeutics Inc continue delivering strong returns2026 Opening Moves & High Accuracy Buy Signal Tips - baoquankhu1.vn

Mar 30, 2026
pulisher
Mar 30, 2026

Published on: 2026-03-31 11:48:00 - baoquankhu1.vn

Mar 30, 2026
pulisher
Mar 27, 2026

Sentiment Recap: Can Applied Therapeutics Inc continue delivering strong returns2026 Market Mood & Smart Swing Trading Alerts - baoquankhu1.vn

Mar 27, 2026
pulisher
Mar 25, 2026

Panic Selling: Can Applied Therapeutics Inc keep up with sector leaders2026 Technical Patterns & Verified Technical Trade Signals - baoquankhu1.vn

Mar 25, 2026
pulisher
Mar 24, 2026

Published on: 2026-03-25 10:49:57 - baoquankhu1.vn

Mar 24, 2026
pulisher
Mar 23, 2026

Applied Therapeutics shifts social media operations to Cycle Pharmaceuticals - Traders Union

Mar 23, 2026
pulisher
Mar 21, 2026

If You Invested $1,000 in Applied Therapeutics (APLT) - Stock Titan

Mar 21, 2026
pulisher
Mar 21, 2026

Sentiment Review: Is Applied Therapeutics Inc gaining market share2026 Update & Accurate Intraday Trade Tips - baoquankhu1.vn

Mar 21, 2026
pulisher
Mar 21, 2026

Sectors Review: Is Applied Therapeutics Inc backed by strong institutional buyingWeekly Risk Report & Verified Short-Term Trading Plans - baoquankhu1.vn

Mar 21, 2026
pulisher
Mar 21, 2026

AI Stocks: Should I set a stop loss on Applied Therapeutics IncProduct Launch & Smart Allocation Stock Reports - baoquankhu1.vn

Mar 21, 2026
pulisher
Mar 07, 2026

Aug Highlights: Is Applied Therapeutics Inc stock good for income investors2025 Price Targets & Community Consensus Trade Signals - baoquankhu1.vn

Mar 07, 2026
pulisher
Mar 04, 2026

APLT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 04, 2026
pulisher
Feb 22, 2026

Momentum Shift: How does Applied Therapeutics Inc score in quality rankings2025 Market Overview & Growth Oriented Trading Recommendations - baoquankhu1.vn

Feb 22, 2026
pulisher
Feb 20, 2026

Should you buy the dip on Applied Therapeutics Inc.Watch List & High Accuracy Buy Signal Tips - mfd.ru

Feb 20, 2026
pulisher
Feb 19, 2026

IPO Launch: Can Applied Therapeutics Inc keep up with sector leadersDollar Strength & Advanced Swing Trade Entry Alerts - baoquankhu1.vn

Feb 19, 2026
pulisher
Feb 15, 2026

Can Applied Therapeutics Inc. keep up with sector leadersMarket Sentiment Review & Smart Allocation Stock Reports - mfd.ru

Feb 15, 2026
pulisher
Feb 13, 2026

[15-12G] Applied Therapeutics, Inc. SEC Filing - Stock Titan

Feb 13, 2026
pulisher
Feb 11, 2026

Will Applied Therapeutics Inc. stock benefit from sector rotationJuly 2025 Intraday Action & Community Shared Stock Ideas - mfd.ru

Feb 11, 2026
pulisher
Feb 09, 2026

Highs Report: What are Applied Therapeutics Incs recent SEC filings showing2025 Price Action Summary & Technical Pattern Based Signals - baoquankhu1.vn

Feb 09, 2026
pulisher
Feb 09, 2026

Aug Mood: Is VivoSim Labs Inc benefiting from innovation trendsQuarterly Market Summary & Pattern Based Trade Signal System - baoquankhu1.vn

Feb 09, 2026
pulisher
Feb 04, 2026

Cycle Group acquires Applied Therapeutics to expand rare disease portfolio By Investing.com - Investing.com Nigeria

Feb 04, 2026
pulisher
Feb 04, 2026

Applied Therapeutics completes merger and Nasdaq delisting move - The Globe and Mail

Feb 04, 2026
pulisher
Feb 03, 2026

Cycle Group Holdings Limited completed the acquisition of Applied Therapeutics, Inc.. - marketscreener.com

Feb 03, 2026
pulisher
Feb 03, 2026

Applied Therapeutics completes merger with Cycle Group Holdings, delists from Nasdaq - Investing.com

Feb 03, 2026
pulisher
Feb 03, 2026

Cycle Group Holdings Acquires Applied Therapeutics - Contract Pharma

Feb 03, 2026
pulisher
Feb 03, 2026

Cycle Group acquires Applied Therapeutics to expand rare disease portfolio - Investing.com

Feb 03, 2026
pulisher
Feb 03, 2026

Applied Therapeutics Announces Board and Management Changes Following Merger - TradingView

Feb 03, 2026
pulisher
Feb 03, 2026

Applied Therapeutics, Inc. Announces Management Changes - marketscreener.com

Feb 03, 2026
pulisher
Feb 03, 2026

Cycle Pharmaceuticals Completes Acquisition of Applied Therapeutics - Business Wire

Feb 03, 2026
pulisher
Feb 02, 2026

Sectors Review: Will Applied Therapeutics Inc benefit from seasonalityGap Up & Expert Curated Trade Ideas - baoquankhu1.vn

Feb 02, 2026
pulisher
Feb 02, 2026

Earnings Recap: Can EFCPRA reach all time highs this yearRate Cut & Smart Swing Trading Techniques - baoquankhu1.vn

Feb 02, 2026
pulisher
Feb 02, 2026

APLT Stock Chart | APPLIED THERAPEUTICS INC (NASDAQ:APLT) - ChartMill

Feb 02, 2026
pulisher
Jan 31, 2026

Published on: 2026-02-01 03:43:48 - baoquankhu1.vn

Jan 31, 2026
pulisher
Jan 30, 2026

Cycle Pharmaceuticals Announces Further Extension of Applied Therapeutics Tender Offer - marketscreener.com

Jan 30, 2026
pulisher
Jan 30, 2026

Cycle Pharmaceuticals Announces Extension of Applied Therapeutics Tender Offer - Business Wire

Jan 30, 2026
pulisher
Jan 30, 2026

Cycle extends tender offer deadline for Applied Therapeutics acquisition By Investing.com - Investing.com Nigeria

Jan 30, 2026
pulisher
Jan 29, 2026

What chart patterns are forming on Applied Therapeutics Inc.Layoff News & Detailed Earnings Play Alerts - mfd.ru

Jan 29, 2026
pulisher
Jan 29, 2026

Applied Therapeutics (APLT) Updates on Cycle Group's Acquisition Offer - GuruFocus

Jan 29, 2026
pulisher
Jan 29, 2026

Cycle extends tender offer deadline for Applied Therapeutics acquisition - Investing.com

Jan 29, 2026
pulisher
Jan 29, 2026

Applied Therapeutics Shares Letter to Stockholders Recommending Tender of Shares Following Offer Expiration Extension - The Manila Times

Jan 29, 2026

Applied Therapeutics Inc Stock (APLT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$28.53
price up icon 3.67%
$50.10
price up icon 1.23%
$103.45
price up icon 1.85%
$136.34
price up icon 0.97%
$144.12
price up icon 2.54%
ONC ONC
$295.27
price up icon 1.54%
Cap:     |  Volume (24h):